A Phase I/II Study of Vorinostat (SAHA), Cladribine (2-CdA), and Rituximab Shows Significant Activity in Previously Untreated Mantle Cell Lymphoma

Stephen E. Spurgeon; Andy I. Chen; Craig Okada; Samir Parekh; Violetta V. Leshchenko; Gundula Palmbach; Bashi Ratterree; N. Subbiah; Christine Capper; Elliot Epner

doi:10.1182/blood.v118.21.441.441

A Phase I/II Study of Vorinostat (SAHA), Cladribine (2-CdA), and Rituximab Shows Significant Activity in Previously Untreated Mantle Cell Lymphoma

Identifier:nobleid.org/w1/20260515/B782834B

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/B782834B.svg?ark=w1%2F20260515%2FB782834B)](https://nobleid.org/work/w1/20260515/B782834B)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Violetta V. Leshchenko

Claim authorship of this work

A Phase I/II Study of Vorinostat (SAHA), Cladribine (2-CdA), and Rituximab Shows Significant Activity in Previously Untreated Mantle Cell Lymphoma

Identifier:nobleid.org/w1/20260515/B782834B

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/B782834B.svg?ark=w1%2F20260515%2FB782834B)](https://nobleid.org/work/w1/20260515/B782834B)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Violetta V. Leshchenko

Claim authorship of this work